Crystal's MCW Coder Hub🧬ICD-10-CM Code: B95.4 - Other streptococcus as the cause of diseases classified elsewhere
Description
B95.4 - Other streptococcus as the cause of diseases classified elsewhere:
Explanation: Code B95.4 functions strictly as a secondary, supplemental diagnosis utilized to identify specific bacterial etiologic agents responsible for an infectious disease process categorized within an alternate chapter of the ICD-10-CM classification system. Specifically, this code captures streptococcal strains that taxonomically do not fall under the classifications of Group A, Group B, Streptococcus pneumoniae, or Enterococcus. The utilization of this code as a primary or principal diagnosis is strictly contraindicated under all coding conventions. Its application is reserved exclusively for clinical scenarios wherein the diagnostic code for the primary condition (the anatomical manifestation of the infection) lacks inherent specification of the causative organism, and concomitant microbiological evidence definitively confirms an “other” streptococcal strain.
Clinically and microbiologically, this classification encompasses a diverse array of pathogens. Most frequently, it denotes the Viridans group streptococci (VGS), a large cohort of commensal flora predominantly residing within the human oral cavity, gastrointestinal tract, and genitourinary system (e.g., S. mutans, S. mitis, S. sanguinis, S. salivarius). While typically benign, these organisms emerge as formidable opportunistic pathogens following mucosal disruption, frequently precipitating subacute infective endocarditis or profound deep-space odontogenic infections.
Furthermore, this code captures Streptococcus bovis (a Group D non-enterococcal streptococcus). The clinical identification of S. bovis—most notably its biotype I, contemporaneously reclassified within scientific nomenclature as Streptococcus gallolyticus—carries profound diagnostic implications. Its isolation from blood cultures is unequivocally correlated with concomitant occult gastrointestinal malignancies, specifically colorectal adenocarcinoma. Consequently, the meticulous documentation and coding of this specific organism are paramount, as they clinically justify extensive subsequent gastroenterological evaluations. Additionally, B95.4 encompasses Group C and Group G streptococci (such as S. dysgalactiae), organisms that frequently mimic Group A streptococcal pathogenesis in severe purulent skin and soft tissue infections or acute pharyngitis.
From an epidemiological, public health, and health administration perspective, the rigorous deployment of this supplemental code is indispensable. It facilitates the precise longitudinal tracking of atypical invasive streptococcal diseases across diverse patient populations. Furthermore, it assists in the critical evaluation of antimicrobial stewardship programs by enabling data analysts to differentiate these relatively susceptible organisms from highly resistant enterococcal strains (such as Vancomycin-Resistant Enterococcus, or VRE). Methodologically, the application of B95.4 fulfills the mandatory “Use additional code to identify organism” instructional notations pervasive throughout the organ-system chapters of the ICD-10-CM tabular list.
Top Related/Alternative Codes
In circumstances where the etiologic organism is not definitively identified as an “other” streptococcal species by laboratory analysis, or when a more comprehensive combination code is clinically applicable based on the disease manifestation, the following alternative classifications must be critically evaluated. The precise selection is fundamentally contingent upon accurate microbiological identification (e.g., Lancefield antigen grouping, hemolysis patterns) and robust clinical documentation from the attending physician:
-
B95.0 - Streptococcus, group A, as the cause of diseases classified elsewhere: Designated for the identification of Group A Streptococcus (e.g., Streptococcus pyogenes). This code is frequently utilized in conjunction with diagnoses indicating severe, rapidly progressing soft tissue infections, such as necrotizing fasciitis, acute rheumatic fever manifestations, or severe acute pharyngitis.
-
B95.1 - Streptococcus, group B, as the cause of diseases classified elsewhere: Designated for the identification of Group B Streptococcus (e.g., Streptococcus agalactiae). This pathogen represents a critical concern within perinatology, necessitating this code in the context of neonatal early-onset sepsis, peripartum maternal chorioamnionitis, and specific invasive infections in immunocompromised adults.
-
B95.2 - Enterococcus as the cause of diseases classified elsewhere: Assigned to denote infections of an enterococcal etiology (e.g., Enterococcus faecalis, Enterococcus faecium). Taxonomically historically linked to Group D streptococci, they are clinically distinct and frequently implicated in highly recalcitrant hospital-acquired genitourinary infections, intra-abdominal abscesses, and central line-associated bloodstream infections (CLABSIs).
-
B95.3 - Streptococcus pneumoniae as the cause of diseases classified elsewhere: Appropriate for the clinical documentation of pneumococcal infections acting as the etiology for secondary anatomical manifestations outside the pulmonary system, such as pneumococcal mastoiditis, bacterial meningitis, or hematogenous osteomyelitis.
-
B95.5 - Unspecified streptococcus as the cause of diseases classified elsewhere: Utilized in scenarios where the clinical documentation confirms a generalized streptococcal etiology, but the precise species or serogroup remains either unidentified or unrecorded by the physician; however, clinical documentation integrity (CDI) practices dictate that its use should be rigorously minimized through provider queries to ascertain definitive microbiological identification whenever clinically feasible.
-
A41.53 - Sepsis due to other streptococcus: A comprehensive combination code utilized in lieu of B95.4 for patients presenting with confirmed systemic inflammatory response syndrome (SIRS) and bacteremia secondary to a Viridans or Group C/G streptococcal infection.
Code Tree (Hierarchy)
The hierarchical structure of the ICD-10-CM classification system is purposefully designed to delineate the specific categorization of infectious agents, structurally decoupling them from localized anatomical sites. This is a vestige of the historical “dagger and asterisk” etiology/manifestation convention:
This structural paradigm underscores the classification’s mechanism for managing complex pathologies that require multiple coordinated codes to accurately portray the clinical scenario. Category B95 acts specifically as a distinct repository for etiologic agents that function solely as secondary descriptors, providing critical granularity to primary localizing pathologies found in other chapters (e.g., Chapter 9 for Circulatory System, Chapter 10 for Respiratory System).
Exclusives/Inclusives
-
Includes:
-
Infectious disease processes precipitated by the diverse members of the Viridans group streptococci (e.g., S. salivarius, S. sanguinis, S. mutans, S. mitis, S. anginosus group).
-
Pathologies resulting from infections caused by Streptococcus bovis (Group D, non-enterococcus) and its modern taxonomic equivalents (e.g., S. gallolyticus).
-
Systemic or localized infections caused by Group C and Group G streptococci.
-
Any definitively specified streptococcal pathogen acting as the primary etiology for a condition classified within an alternative body system, provided taxonomic guidelines confirm it does not fall under groups A, B, or S. pneumoniae.
-
-
Excludes1 (Mutually Exclusive - Cannot be coded together):
-
Streptococcal infection, unspecified site (A49.1)
-
Other streptococcal arthritis and polyarthritis (M00.2- category, encompassing specific joint codes)
-
Explanation: The principle of an Excludes1 edit is rooted in strict mutual exclusivity. The aforementioned conditions are represented by highly specific combination codes or pre-coordinated categories that inherently incorporate the “other streptococcus” organism directly within their foundational diagnostic definitions. Consequently, the dual application of B95.4 alongside these codes violates the fundamental principle of coding parsimony. Such dual reporting constitutes an explicit Excludes1 instructional violation, rendering the coding sequence procedurally invalid. From a revenue cycle perspective, these violations are routinely intercepted by automated clearinghouse scrubbing software, resulting in immediate claim denials and delayed reimbursement.
Reimbursement & Clinical Documentation Indicators
-
HCC Information: Code B95.4, when evaluated in strict isolation, does not map to a Hierarchical Condition Category (HCC) for the purposes of Medicare Advantage risk adjustment (CMS-HCC model). Rather, the applicable HCC risk score and corresponding financial weight are entirely contingent upon the primary diagnosis code (for instance, acute infective endocarditis, severe localized abscess, or acute osteomyelitis) to which B95.4 is clinically appended. Nevertheless, its inclusion remains absolutely vital. During retrospective Risk Adjustment Data Validation (RADV) audits, the presence of the specific organism code substantiates the acuity, microbiological complexity, and medical necessity of the primary condition, thereby protecting the primary HCC from auditor deletion2.
-
MS-DRG and APR-DRG Impacts: Within specific iterations of the Medicare Severity Diagnosis Related Groups (MS-DRG) grouper software, B95.4 is formally designated as a CC (Complication or Comorbidity). Its substantive impact on the final inpatient MS-DRG assignment remains heavily dependent upon the nature of the principal diagnosis. When appropriately sequenced as a secondary diagnosis, a CC designation has the potential to trigger a DRG shift to a higher tier. Furthermore, within the All Patient Refined Diagnosis Related Groups (APR-DRG) system utilized by many commercial payers and state Medicaid programs, the addition of a specific bacterial pathogen frequently elevates the Severity of Illness (SOI) and Risk of Mortality (ROM) subclasses. This systemic elevation subsequently increases the relative weight of the DRG, thereby accurately acknowledging the heightened hospital resource consumption—such as infectious disease consultations and prolonged intravenous antimicrobial therapy—required to manage culture-positive bacterial infections.
-
Clinical Documentation Integrity (CDI) Requisites and Query Protocols: It is a foundational, non-negotiable tenet of medical coding ethics and compliance that pathology, serology, and microbiology laboratory results cannot be independently interpreted by the coding professional to assign a diagnosis. Therefore, the mere presence of a positive blood, tissue, or fluid culture demonstrating Streptococcus viridans or Streptococcus bovis does not inherently justify the assignment of B95.4. The attending clinician must explicitly document the causal, diagnostic relationship between the identified organism and the localized infection within the body of the medical record (e.g., stating “Acute cholecystitis secondary to Streptococcus bovis infection” in the progress notes or discharge summary). If a positive culture is present in the record but the physician merely documents “cellulitis” or “endocarditis,” the CDI specialist or coder is obligated to issue a compliant, non-leading query to the provider requesting confirmation of the organism’s clinical significance and its linkage to the primary disease process.
CPT/HCPCS Specific Information
(Note: Given that B95.4 represents an alphanumeric ICD-10-CM diagnosis classification utilized to comprehensively demonstrate medical necessity and disease etiology, rather than a distinct procedural intervention performed by a provider, direct CPT/HCPCS procedural metrics are clinically inapplicable. However, the diagnosis code fundamentally supports the medical necessity for associated procedures.)
-
CPT/HCPCS Code(s): N/A (Directly). However, the presence of B95.4 strongly supports the medical necessity for related diagnostic and therapeutic CPT codes, including but not limited to:
-
WRVU: N/A
-
Global periods: N/A
-
Assistant Payable: N/A
-
Bundling & NCCI Edits: N/A
Coding Examples
Example 1: Subacute Infective Endocarditis (Viridans Group)
-
Clinical Scenario: A 65-year-old patient with a known history of severe rheumatic mitral valve disease is admitted presenting with a prolonged low-grade fever, progressive malaise, and a newly auscultated cardiac murmur. A transesophageal echocardiogram (TEE) reveals a definitive, mobile vegetation on the anterior leaflet of the mitral valve. Three sets of serial blood cultures drawn over 24 hours consistently yield positive results for Streptococcus sanguinis (a prominent member of the Viridans group). The attending infectious disease specialist’s final discharge summary lists the principal diagnosis as “Subacute infective endocarditis caused by Viridans streptococcus.”
-
Coding:
-
Rationale: The I33.0 code accurately identifies the severe, acute inflammation of the endocardial tissue but inherently lacks any specificity regarding the causative bacterial pathogen. The supplementary addition of B95.4 is explicitly mandated by the tabular instruction “Use additional code (B95-B97) to identify infectious agent” located at the I33 category level. This captures the complete clinical etiology.
Example 2: Acute Bacterial Cholecystitis (Streptococcus bovis)
-
Clinical Scenario: A patient undergoes an emergency laparoscopic cholecystectomy for acute, severe calculous cholecystitis. Post-operative intra-abdominal fluid and bile cultures return strongly positive for Streptococcus gallolyticus (formerly Streptococcus bovis biotype I). Upon reviewing the lab results, the attending surgeon updates the progress notes, documenting, “Acute calculous cholecystitis with secondary infection driven by Streptococcus bovis; patient requires urgent outpatient colonoscopy due to the high association of this pathogen with colorectal neoplasms.”
-
Coding:
-
Primary: K81.0 (Acute cholecystitis)
-
Secondary: K80.20 (Calculus of gallbladder without cholecystitis without obstruction) (Note: Depending on the exact syntactic documentation in the operative report, a combination code such as K80.00 might be utilized as the primary code replacing K81.0 and K80.20). * Tertiary: B95.4 (Other streptococcus as the cause of diseases classified elsewhere)
-
-
Rationale: Biliary tract infections can occasionally be seeded by translocated gastrointestinal flora such as S. bovis. Because the primary diagnostic codes mapping to the gallbladder and biliary tract lack pathogen specificity, the B95.4 code must be appended to construct a comprehensive, accurate clinical picture of the infectious etiology. Furthermore, capturing this code may help validate the medical necessity of the subsequent screening or diagnostic colonoscopy.
Example 3: Severe Deep Space Odontogenic Infection (Ludwig’s Angina)
-
Clinical Scenario: A 42-year-old male presents to the emergency department with massive submandibular swelling, trismus, and airway compromise following an untreated dental caries. He is diagnosed with Ludwig’s angina and taken for emergent surgical decompression and drainage of the submandibular space. Operative deep tissue cultures isolate a heavy growth of Streptococcus anginosus (a subgroup of the Viridans streptococci known for abscess formation). The maxillofacial surgeon documents “Ludwig’s angina secondary to Streptococcus anginosus infection.”
-
Coding:
-
Rationale: Ludwig’s angina is classified under cellulitis and abscess of the mouth (K12.2). As this condition is predominantly polymicrobial but frequently driven by the S. anginosus group, utilizing B95.4 based on the explicit provider documentation accurately captures the complex microbiological etiology of this life-threatening fascial space infection.
Example 4: Counter-Example (Improper Usage - Excludes1 Violation)
-
Clinical Scenario: A patient presents to the intensive care unit in a state of profound distributive shock and multi-organ dysfunction. Blood cultures rapidly confirm the presence of Group G Streptococcus. The critical care physician documents the final diagnosis as “Severe Sepsis with septic shock due to Group G Strep bacteremia.”
-
Coding:
-
Rationale: In this complex clinical scenario, the application of B95.4 is strictly prohibited by ICD-10-CM coding conventions. The specific primary diagnostic code A41.53 already functions as a fully delineated combination code that encompasses both the systemic inflammatory response (sepsis) and the precise causative pathogen class (“other streptococcus,” which definitively includes Group G). Appending B95.4 to this claim would constitute an Excludes1 edit violation, as the specific bacterial pathogen is inherently captured and defined within the primary systemic diagnostic code.
Sources:
1 ICD-10-CM Official Guidelines for Coding and Reporting, Section I.C.1.b (Use of specific infectious agent codes)
2 CMS-HCC Risk Adjustment Model mappings
3 Medicare Severity Diagnosis Related Groups (MS-DRG) Definitions Manual